Literature DB >> 10343175

Mineralocorticoids and glucocorticoids cooperatively increase salt intake and angiotensin II receptor binding in rat brain.

S G Shelat1, J L King, L M Flanagan-Cato, S J Fluharty.   

Abstract

Mineralocorticoids, such as deoxycorticosterone acetate (DOCA), and angiotensin II (AngII) act synergistically in the brain to elicit salt appetite. Glucocorticoids, such as dexamethasone (DEX), also may enhance the behavioral effects of DOCA and AngII. However, the brain regions involved in these behavioral interactions have not been elucidated. This study tested the hypothesis that DEX potentiates the effects of DOCA on AngII binding, especially at the AT1 receptor. We confirmed that DEX potentiated the effects of DOCA on salt appetite. Concomitantly, steroid-specific and region-specific changes in AT1 binding were noted. Specifically, in the hypothalamic paraventricular nucleus, treatment with DEX or DOCA + DEX increased AT1 binding. In the subfornical organ (SFO) and area postrema, there was an increase in AT1 binding when both steroids were combined, but not when given individually. However, there was no change in AT2 binding in any brain region studied and no change in AT1 or AT2 binding to either receptor subtype in the pituitary. The results indicate that DOCA and DEX may increase the sensitivity of the brain to the behavioral and physiological actions of AngII by upregulating AT1 receptors in the SFO and area postrema.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10343175     DOI: 10.1159/000054436

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  16 in total

Review 1.  Angiotensin and calcium signaling in the pituitary and hypothalamus.

Authors:  Cecilia Suárez; Isabel García Tornadú; Carolina Cristina; Jorge Vela; Arturo González Iglesias; Carlos Libertun; Graciela Díaz-Torga; Damasia Becu-Villalobos
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

2.  Age-related changes in thirst, salt appetite, and arterial blood pressure in response to aldosterone-dexamethasone combination in rats.

Authors:  Robert L Thunhorst; Baojian Xue; Terry G Beltz; Alan Kim Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-04-01       Impact factor: 3.619

3.  Richter and sodium appetite: from adrenalectomy to molecular biology.

Authors:  Eric G Krause; Randall R Sakai
Journal:  Appetite       Date:  2007-04-11       Impact factor: 3.868

4.  Nucleus accumbens shell, but not core, tracks motivational value of salt.

Authors:  Amy L Loriaux; Jamie D Roitman; Mitchell F Roitman
Journal:  J Neurophysiol       Date:  2011-06-22       Impact factor: 2.714

5.  Effects of fludrocortisone on water and sodium intake of C57BL/6 mice.

Authors:  Ralph F Johnson; Terry G Beltz; Alan Kim Johnson; Robert L Thunhorst
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-05-27       Impact factor: 3.619

6.  Cushing's syndrome: all variants, detection, and treatment.

Authors:  Susmeeta T Sharma; Lynnette K Nieman
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

Review 7.  The roles of sensitization and neuroplasticity in the long-term regulation of blood pressure and hypertension.

Authors:  Alan Kim Johnson; Zhongming Zhang; Sarah C Clayton; Terry G Beltz; Seth W Hurley; Robert L Thunhorst; Baojian Xue
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-19       Impact factor: 3.619

Review 8.  Glucocorticoid excess and hypertension.

Authors:  Smita Baid; Lynnette K Nieman
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

9.  Differential effects of mineralocorticoid and angiotensin II on incentive and mesolimbic activity.

Authors:  Laura A Grafe; Loretta M Flanagan-Cato
Journal:  Horm Behav       Date:  2015-12-28       Impact factor: 3.587

10.  Glucocorticoids increase salt appetite by promoting water and sodium excretion.

Authors:  Robert L Thunhorst; Terry G Beltz; Alan Kim Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-06-27       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.